BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND TAL1, TCL5, 6886, ENSG00000162367, SCL, P17542, tal-1 AND Diagnosis
11 results:

  • 1. Atezolizumab-induced scleroderma: a rare complication.
    Grant C; Chalasani V; Uchin JM; Dore A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764112
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical and Laboratory Characteristics and Mortality in Korean Patients with Systemic sclerosis: A Nationwide Multicenter Retrospective Cohort Study.
    Moon KW; Lee SS; Lee YJ; Jun JB; Yoo SJ; Ju JH; Chang SH; Choi IA; Kang TY; Lee EB; Lee SG
    J Rheumatol; 2018 Aug; 45(9):1281-1288. PubMed ID: 30008455
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Systemic sclerosis and malignancy.
    Sargin G; Senturk T; Cildag S
    Int J Rheum Dis; 2018 May; 21(5):1093-1097. PubMed ID: 29673080
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Small Cell lung cancer in a 20-year-old Non-Smoking Man with Systemic sclerosis.
    Saito G; Jinta T; Nakaoka H; Kitamura A; Yamaguchi K; Nishimura N
    Intern Med; 2017; 56(12):1549-1552. PubMed ID: 28626182
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Novel risk factors related to cancer in scleroderma.
    Bernal-Bello D; de Tena JG; Guillén-Del Castillo A; Selva-O'Callaghan A; Callejas-Moraga EL; Marín-Sánchez AM; Fonollosa-Pla V; Simeón-Aznar CP
    Autoimmun Rev; 2017 May; 16(5):461-468. PubMed ID: 28285170
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues.
    Yan H; Guan Q; He J; Lin Y; Zhang J; Li H; Liu H; Gu Y; Guo Z; He F
    J Transl Med; 2017 Feb; 15(1):26. PubMed ID: 28178989
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Erasmus syndrome in a marble worker.
    Bello S; Rinaldi A; Trabucco S; Serafino L; Bonali C; Lapadula G
    Reumatismo; 2015 Dec; 67(3):116-22. PubMed ID: 26876191
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The third symptom management research trial in oncology (SMaRT oncology-3): a randomised trial to determine the efficacy of adding a complex intervention for major depressive disorder (depression care for people with lung cancer) to usual care, compared to usual care alone in patients with lung cancer.
    Walker J; Cassidy J; Sharpe M;
    Trials; 2009 Sep; 10():92. PubMed ID: 19793390
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Ulcerative paraneoplastic dermatomyositis secondary to metastatic breast cancer.
    Scheinfeld NS
    Skinmed; 2006; 5(2):94-6. PubMed ID: 16603844
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Systemic scleroderma and sarcoidosis: 3 new cases].
    Bandt MD; Meyer O; Masson C; Peroux-Goumy L; Audran M; Kahn MF
    Ann Med Interne (Paris); 1996; 147(8):590-4. PubMed ID: 9137689
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A monoclonal antibody against basal cells of human epidermis. Potential use in the diagnosis of cervical neoplasia.
    Morhenn VB; Schreiber AB; Soriero O; McMillan W; Allison AC
    J Clin Invest; 1985 Nov; 76(5):1978-83. PubMed ID: 3840497
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.